Sotrovimab: una opción terapéutica en trasplante pulmonar

Gutiérrez Larraya Sánchez Andrade, Rosa; Erro Iribarren, Marta; Aguado Ibáñez, Silvia; Aguilar Pérez, Myriam; Laporta Hernández, Rosalía; López García Gallo, Cristina; Almonacid Sánchez , Carlos; Ussetti Gil, Piedad.
Rev. patol. respir ; 27(1): 11-15, ene.-mar2024. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-231674

Documentos relacionados

  1. Prevalencia de embolia pulmonar en pacientes con infección por COVID-19, abril-diciembre de 2020
  2. [Hypercapnia under controlled mechanical ventilation in patients with high-risk acute pulmonary thromboembolism].
  3. Clinical characteristics and course in emergency department patients with chronic obstructive pulmonary disease and symptomatic acute venous thromboembolic disease: secondary analysis of the ESPHERIA registry.
  4. Vacunas frente a la COVID-19: perfil de seguridad tras un año de seguimiento
  5. Does follow-up D-dimer level help in predicting oxygenation status, ventilatory support requirement, lung fibrosis, and thromboembolic events in coronavirus disease 2019 pneumonia? A prospective observational study in a tertiary care setting in India.
  6. Pulmonary Embolism and Chronic Obstructive Pulmonary Disease.
  7. Vancouver General Hospital Pulmonary Embolism Response Team (VGH PERT): initial three-year experience.
  8. MRA as the Preferred Test for Pulmonary Embolism During the Iodinated Contrast Media Shortage of 2022: A Single-Center Experience.
  9. Impacto de tres años de experiencia en tromboendarterectomía pulmonar
  10. Association between Hispanic or Latino ethnicity and pulmonary embolism severity, management, and in-hospital outcomes.